Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
1
33%
Ph phase_2
2
67%

Phase Distribution

0

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Phase 2Efficacy & side effects
2(66.7%)
N/ANon-phased studies
1(33.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(1)
Other(2)

Detailed Status

unknown2
Completed1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 22 (66.7%)
N/A1 (33.3%)

Trials by Status

completed133%
unknown267%

Recent Activity

0 active trials
Showing 3 of 3
completednot_applicable

The Effect of Peroral Sodium Hyaluronate on the Skin

NCT07065110
unknownphase_2

Role of Hypersensitivity to Female Sex Hormones in Women With Unexplained Recurrent Pregnancy Loss

NCT01175759
unknownphase_2

Evaluation of Efficacy/Safety of EVE-PMS Skin Test Panel

NCT00866437

Clinical Trials (3)

Showing 3 of 3 trials
NCT07065110Not Applicable

The Effect of Peroral Sodium Hyaluronate on the Skin

Completed
NCT01175759Phase 2

Role of Hypersensitivity to Female Sex Hormones in Women With Unexplained Recurrent Pregnancy Loss

Unknown
NCT00866437Phase 2

Evaluation of Efficacy/Safety of EVE-PMS Skin Test Panel

Unknown

All 3 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
3